• Explore /
  • Poster
  • / Efficacy of biomarker-matched therapy in clinical trials for advanced gastrointestinal cancers: A pooled analysis of SCRUM-Japan studies.

Efficacy of biomarker-matched therapy in clinical trials for advanced gastrointestinal cancers: A pooled analysis of SCRUM-Japan studies.

Abstract Poster

Authors

null

Tadayoshi Hashimoto

Department of Gastroenterology and Gastrointestinal Oncology/Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan

Tadayoshi Hashimoto , Takao Fujisawa , Nozomu Machida , Akitaka Makiyama , Shogen Boku , Shigenori Kadowaki , Naoki Takahashi , Eiji Oki , Chigusa Morizane , Yu Sunakawa , Yoshito Komatsu , Naohiro Okano , Taito Esaki , Takashi Ohta , Takeshi Kato , Hiroshi Ozaki , Naoko Iida , Yoshiaki Nakamura , Hideaki Bando , Takayuki Yoshino

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 753)

DOI

10.1200/JCO.2024.42.3_suppl.753

Abstract #

753

Poster Bd #

M8

Abstract Disclosures

Similar Posters

First Author: Herbert Hurwitz

Poster

2015 ASCO Annual Meeting

Molecular profiling of mucinous epithelial ovarian carcinomas (mEOC): Opportunities for clinical trials.

Molecular profiling of mucinous epithelial ovarian carcinomas (mEOC): Opportunities for clinical trials.

First Author: Michael Friedlander

First Author: Kohei Shitara

First Author: Mo Yang